Literature DB >> 18094112

Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2.

Lidice Bernardo1, Alienys Izquierdo, Irina Prado, Delfina Rosario, Mayling Alvarez, Emidalys Santana, Jorge Castro, Rafael Martínez, Rosmari Rodríguez, Luis Morier, Gerardo Guillén, María G Guzmán.   

Abstract

The goal of this study was to compare the immune response and the protection capacity induced by the dengue virus 2 (DENV-2) American and Asian genotypes in Macaca fascicularis monkeys. Animals were infected with American or Asian DENV-2 strains and challenged 1 year later with a DENV-2 Asian genotype strain. The viremia and monkey antibody levels were similar for the different strains after primary and secondary infection; however, the functionality of the antibody response was different. A limited viral replication was demonstrated after the secondary infection in all the monkeys. No virus was isolated in tissue culture, while reverse transcription-PCR showed a late positive reaction in four of five challenged monkeys. The immunoglobulin M response pattern and the detection of antibodies to specific proteins by Western blotting supported the protection data. Despite the demonstration of the protective effect after homologous challenge, a strong anamnestic antibody response was observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18094112      PMCID: PMC2268260          DOI: 10.1128/CVI.00208-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  44 in total

1.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

2.  Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys.

Authors:  Tadeusz J Kochel; Douglas M Watts; Alfonso S Gozalo; Daniel F Ewing; Kevin R Porter; Kevin L Russell
Journal:  J Infect Dis       Date:  2005-01-31       Impact factor: 5.226

3.  Antibody responses to Asian and American genotypes of dengue 2 virus in immunized mice.

Authors:  Lidice Bernardo; Adriana Yndart; Susana Vázquez; Luis Morier; María G Guzmán
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  Research on dengue during World War II.

Authors:  A B SABIN
Journal:  Am J Trop Med Hyg       Date:  1952-01       Impact factor: 2.345

5.  Partial agonist effect influences the CTL response to a heterologous dengue virus serotype.

Authors:  J Zivny; M DeFronzo; W Jarry; J Jameson; J Cruz; F A Ennis; A L Rothman
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

6.  [Polymerase chain reaction for rapid detection and serotyping of dengue virus in clinical samples].

Authors:  D Rosario; M Alvarez; J Díaz; R Contreras; R Rodríguez; S Vázquez; M G Guzmán
Journal:  Rev Panam Salud Publica       Date:  1998-07

7.  Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.

Authors:  Thomas P Monath; Gwendolyn A Myers; Robert A Beck; Michael Knauber; Kelly Scappaticci; Thad Pullano; W Tad Archambault; John Catalan; Chuck Miller; Zhen-Xi Zhang; Sunheang Shin; Konstantin Pugachev; Ken Draper; Inessa S Levenbook; Farshad Guirakhoo
Journal:  Biologicals       Date:  2005-09       Impact factor: 1.856

8.  Fatal dengue hemorrhagic fever in Cuba, 1997.

Authors:  M G Guzmán; M Alvarez; R Rodríguez; D Rosario; S Vázquez; L Vald s; M V Cabrera; G Kourí
Journal:  Int J Infect Dis       Date:  1999       Impact factor: 3.623

Review 9.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

10.  Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.

Authors:  Joseph E Blaney; Christopher T Hanson; Kathryn A Hanley; Brian R Murphy; Stephen S Whitehead
Journal:  BMC Infect Dis       Date:  2004-10-04       Impact factor: 3.090

View more
  20 in total

1.  Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.

Authors:  Leah C Katzelnick; Magelda Montoya; Lionel Gresh; Angel Balmaseda; Eva Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

2.  Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes.

Authors:  Lidice Bernardo; Osmel Fleitas; Alequis Pavón; Lisset Hermida; Gerardo Guillén; Maria G Guzman
Journal:  Clin Vaccine Immunol       Date:  2009-09-02

Review 3.  Dengue: knowledge gaps, unmet needs, and research priorities.

Authors:  Leah C Katzelnick; Josefina Coloma; Eva Harris
Journal:  Lancet Infect Dis       Date:  2017-02-07       Impact factor: 25.071

4.  Homotypic Dengue Virus Reinfections in Nicaraguan Children.

Authors:  Jesse J Waggoner; Angel Balmaseda; Lionel Gresh; Malaya K Sahoo; Magelda Montoya; Chunling Wang; Janaki Abeynayake; Guillermina Kuan; Benjamin A Pinsky; Eva Harris
Journal:  J Infect Dis       Date:  2016-03-16       Impact factor: 5.226

5.  Viremia and the magnitude of the immune response upon infection of green monkeys with dengue virus type 2 are strain-dependent.

Authors:  Jorge Martín; Lisset Hermida; Jorge Castro; Yaremis Romero; Jane Cardosa; Gerardo Guillén
Journal:  Curr Microbiol       Date:  2009-09-26       Impact factor: 2.188

6.  The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.

Authors:  Lázaro Gil; Ernesto Marcos; Alienys Izquierdo; Laura Lazo; Iris Valdés; Peris Ambala; Lucy Ochola; Rikoi Hitler; Edith Suzarte; Mayling Álvarez; Prisilla Kimiti; James Ndung'u; Thomas Kariuki; María Guadalupe Guzmán; Gerardo Guillén; Lisset Hermida
Journal:  Immunol Cell Biol       Date:  2014-09-02       Impact factor: 5.126

7.  Serotype-specific host responses in rhesus macaques after primary dengue challenge.

Authors:  Andrew C Hickey; Jacob A Koster; Claudia M Thalmann; Kathy Hardcastle; Phaik-Hooi Tio; Mary J Cardosa; Katharine N Bossart
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

8.  Immune correlates of protection for dengue: State of the art and research agenda.

Authors:  Leah C Katzelnick; Eva Harris
Journal:  Vaccine       Date:  2017-07-28       Impact factor: 3.641

9.  Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy.

Authors:  Katherine M Smith; Kavita Nanda; Carla J Spears; Amanda Piper; Mariana Ribeiro; Michelle Quiles; Caitlin M Briggs; Gwynneth S Thomas; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez; Victoria McCarl
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

10.  Dengue virus serotype 2 from a sylvatic lineage isolated from a patient with dengue hemorrhagic fever.

Authors:  Jane Cardosa; Mong How Ooi; Phaik Hooi Tio; David Perera; Edward C Holmes; Khatijar Bibi; Zahara Abdul Manap
Journal:  PLoS Negl Trop Dis       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.